Парадоксы эволюции. Как наличие ресурсов и отсутствие внешних угроз приводит к самоуничтожению вида и что мы можем с этим сделать

10. Mathieu-Denoncourt A., Giacomuccia S., Duperthuy M. (2021). Secretome of Vibrio cholerae. Chapter in Book: Vibrios (pre-print).

11. Briffa K., Jones P., Schweingruber F., Osborn T. J. (1998). Influence of volcanic eruptions on Northern Hemisphere summer temperature over the past 600 years. Nature 393, 450–455.

12. Tanguy J. C., Ribière C., Scarth A., Tjetjep W. S. (1998). Victims from volcanic eruptions: a revised database. Bull Volcanol 60, 137–144.

13. De Haan L., Hirst R. T. (2004). Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review). Molecular Membrane Biology, 21, 77–92.

14. Odumosu O., Nicholas D., Yano H., Langridge W. (2010). Toxins, 2, 1612–1645.

15. Thompson J. N. (1999). Specific hypotheses on the geographic mosaic of coevolution. Am. Nat. 153, S1–S14.

16. Turner W. C., Kamath P. L., van Heerden H., Huang Y.-H., Barandongo Z. R., Bruce S. A., Kausrud K. (2021). The roles of environmental variation and parasite survival in virulence-transmission relationships. R. Soc. Open Sci. 8: 210088.

17. Wolinska J., King K. C. (2009). Environment can alterselection in host – parasite interactions. Trends Parasitol. 25, 236–244.

18. O’Neal C. J., Jobling M. G., Holmes R. K., Hol W. G. (2005). Structural basis for the activation of cholera toxin by human ARF6-GTP. Science, 309, 1093–1096.

19. Jørgensen R., Purdy A. E., Fieldhouse R. J., Kimber M. S., Bartlett D. H., Merrill A. R. (2008). Cholix toxin, a novel ADP-ribosylating factor from Vibrio cholerae. J Biol Chem; 283 (16): 10671–8.

20. Liu S., Bachran C., Gupta P., Miller-Randolph S., Wang H., Crown D., Zhang Y., Wein A. N., Singh R., Fattah R., Leppla S. H. (2012). Diphthamide modification on eukaryotic elongation factor 2 is needed to assure fidelity of mRNA translation and mouse development. Proc Natl Acad Sci U S A; 109 (34): 13817–22.

21. Gaubitz M. (2006). Epidemiology of connective tissue disorders. Rheumatology (Oxford); 45 Suppl 3:iii3–4.

22. Gao K., Shen X., Lin Y., Zhu X. Z., Lin L. R., Tong M. L., Xiao Y., Zhang H. L., Liang X. M., Niu J. J., Liu L. L., Yang T. C. (2018). Origin of Nontreponemal Antibodies During Treponema pallidum Infection: Evidence From a Rabbit Model. J Infect Dis.; 218 (5): 835–843.

23. Carranza G., Angius F., Ilioaia O., Solgadi A., Miroux B., Arechaga I. (2017). Cardiolipin plays an essential role in the formation of intracellular membranes in Escherichia coli. Biochim Biophys Acta Biomembr; 1859 (6): 1124–1132.

24. Arechaga I., Miroux B., Karrasch S., Huijbregts R., de Kruijff B., Runswick M. J., Walker J. E. (2000). Characterisation of new intracellular membranes in Escherichia coli accompanying large scale over-production of the b subunit of F(1)F(o) ATP synthase. FEBS Lett., 482, pp. 215–219.

25. Mileykovskaya E., Dowhan W. (2009). Cardiolipin membrane domains in prokaryotes and eukaryotes Biochim. Biophys. Acta, 1788, pp. 2084–2091.

26. Schlame M. (2008). Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes J. Lipid Res., 49, pp. 1607–1620.

27. Romantsov T., Guan Z., Wood J. M. (2009). Cardiolipin and the osmotic stress responses of bacteria Biochim. Biophys. Acta, 1788, pp. 2092–2100.

28. Pieterse E., van der Vlag J. (2014). Breaking immunological tolerance in systemic lupus erythematosus. Frontiers in Immunology, 8, pp. 1–8.

29. Munoz L. E., Van Bavel C., Franz S., Berden J., Herrmann M., van der Vlag J. (2008). Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus, 17: 371–5.

30. Skiljevic D., Jeremic I., Nikolic M., Andrejevic S., Sefik-Bukilica M., Stojimirovic B., Bonaci-Nikolic B. (2013). Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement. Clin Chem Lab Med, 51: 1083–91.

31. Shiozawa S. (2010). The cause of systemic lupus erythematosus: implication of ‘self-organized criticality theory of autoimmunity’ on the pathogenesis of systemic lupus erythematosus. Int. J. Clin. Rheumatol. 5 (6), 619–626.

32. Bas de Laat H., Derksen R. H., de Groot P. G. (2004). β2-glycoprotein I, the playmaker of the antiphospholipid syndrome, Clin. Immunol., 112, 161–168.

33. Allen K. L., Fonseca F. V., Betapudi V., Willard B., Zhang J., McCrae K. R. (2012). A novel pathway for human endothelial cell activation by antiphospholipid/ anti-β2 glycoprotein I antibodies, Blood, 119, 884–893.

Глава XV. Killing for fun

Что ты получишь, если смешаешь психически больного одиночку с обществом, которое игнорирует его и обращается с ним как с мусором?!

Я скажу, что ты получишь! Ты получишь то, что заслужил!

Джокер, Тодд Филлипс, 2019

Две концепции рака